Talk:Withania somnifera (botany)

Revision as of 04:50, 11 July 2016 by >Catharsis (Created page with "{{proofread}} {{substanceBox/Ashwagandha}} {| |- |- | ''Summary sheet: Ashwagandha'' |} '''Ashwagandha''', also known as '''Withania somnifera''', '''I...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Template:Proofread Template:SubstanceBox/Ashwagandha

Summary sheet: Ashwagandha

Ashwagandha, also known as Withania somnifera, Indian ginseng, poison gooseberry and winter cherry, is a Adaptogenic[1] plant in the Solanaceae or nightshade family. It is used as a herb in Ayurvedic medicine. Ashwagandha contains flavonoids such as Withanolide A and Withaferin-A, which are believed to be responsible for Ashwagandha's psychoactive properties.

Ashwagandha has been well-researched for a multitude of health benefits, including anxiety reduction[2], Stress reduction[3], physical performance enhancing[4][5], depression relief[6], and fatigue relief[7].

Chemistry

 

This chemistry section is incomplete.

You can help by adding to it.

Pharmacology

Theanine is structurally similar to the excitatory neurotransmitter glutamate, and in accordance, binds to glutamate receptors, though with much lower affinity in comparison. Specifically, it binds to ionotropic glutamate receptors including the AMPA and kainate receptors and, to a lesser extent, the NMDA receptor.[8][9][10][11] It acts as an antagonist of the former two sites[12] and as an agonist of the latter site.[13] In addition, it inhibits glutamine transporters and glutamate transporters, and thus acts as reuptake inhibitor of glutamine and glutamate.[14][15][16]

Theanine increases dopamine, GABA, and glycine levels in various areas of the brain.[17][18][19][20] It also effects serotonin in a manner which is still a matter of debate in the scientific community, with separate studies showing increases and decreases in brain serotonin levels using similar experimental protocols.[21][22]

These various changes in neurotransmitter levels contribute to the calming and nootropic properties of theanine.

Subjective effects

The effects listed below are based upon the subjective effect index and personal experiences of PsychonautWiki contributors. The listed effects will rarely (if ever) occur all at once, but heavier dosages will increase the chances and are more likely to induce a full range of effects.

Physical effects

Cognitive effects

Toxicity and harm potential

Theanine is non-addictive, is not known to cause brain damage, and has an extremely low toxicity relative to dose. Similar to many other nootropics drugs, there are relatively few physical side effects associated with acute theanine exposure. Various studies have shown that in reasonable doses in a careful context, it presents no negative cognitive, psychiatric or toxic physical consequences of any sort.

It is strongly recommended that one use harm reduction practices when using this drug.

Tolerance and addiction potential

Theanine is not habit-forming and the desire to use it can actually decrease with use. It is most often self-regulating.

Tolerance to the effects of theanine are built after prolonged and repeated usage. After that, it takes about 7 days for the tolerance to be reduced to half and 14 days to be back at baseline (in the absence of further consumption). Theanine presents cross-tolerance with no other known compounds, meaning that after the consumption of theanine all other psychoactive compounds will not have a reduced effect.

 

This legality section is a stub.

As such, it may contain incomplete or wrong information. You can help by expanding it.

Theanine is unscheduled across the world and is not known to be specifically illegal within any country.

  • United Kingdom - This drug is illegal under the Psychoactive Substance Act, which came into effect on May 26th, 2016.[24]

See also

References

  1. Withania somnifera: an Indian ginseng. |http://www.ncbi.nlm.nih.gov/pubmed/17959291
  2. Naturopathic care for anxiety: a randomized controlled trial ISRCTN78958974. | http://www.ncbi.nlm.nih.gov/pubmed/19718255
  3. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. | http://www.ncbi.nlm.nih.gov/pubmed/23439798
  4. Effects of Withania somnifera (Ashwagandha) and Terminalia arjuna (Arjuna) on physical performance and cardiorespiratory endurance in healthy young adults. | http://www.ncbi.nlm.nih.gov/pubmed/21170205
  5. Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial.| http://www.ncbi.nlm.nih.gov/pubmed/26609282
  6. A double-blind, placebo-controlled evaluation of the anxiolytic efficacy ff an ethanolic extract of withania somnifera. | http://www.ncbi.nlm.nih.gov/pubmed/21407960
  7. Naturopathic care for anxiety: a randomized controlled trial ISRCTN78958974. | http://www.ncbi.nlm.nih.gov/pubmed/19718255
  8. The neuropharmacology of L-theanine(N-ethyl-L-glutamine): a possible neuroprotective and cognitive enhancing agent (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/17182482
  9. Inhibition by theanine of binding of [3H]AMPA, [3H]kainate, and [3H]MDL 105,519 to glutamate receptors (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/12596867
  10. Neuroprotective effects of theanine and its preventive effects on cognitive dysfunction (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/21477654
  11. Neuroprotective effects of the green tea components theanine and catechins (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/12499631
  12. Neuroprotective effects of the green tea components theanine and catechins (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/12499631
  13. Behavioral and molecular evidence for psychotropic effects in L-theanine (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/21861094
  14. Neuroprotective effects of the green tea components theanine and catechins (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/12499631
  15. Inhibition of glutamate transporter by theanine enhances the therapeutic efficacy of doxorubicin (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/11325559
  16. Theanine and glutamate transporter inhibitors enhance the antitumor efficacy of chemotherapeutic agents (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/14643924
  17. The neuropharmacology of L-theanine(N-ethyl-L-glutamine): a possible neuroprotective and cognitive enhancing agent (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/17182482
  18. Behavioral and molecular evidence for psychotropic effects in L-theanine (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/21861094
  19. Theanine, r-glutamylethylamide, increases neurotransmission concentrations and neurotrophin mRNA levels in the brain during lactation (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/17904164
  20. Effect of theanine, r-glutamylethylamide, on brain monoamines and striatal dopamine release in conscious rats (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/9566605
  21. Effect of theanine, r-glutamylethylamide, on brain monoamines and striatal dopamine release in conscious rats (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/9566605
  22. Theanine-induced reduction of brain serotonin concentration in rats (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/9614715
  23. A combination of green tea extract and l-theanine improves memory and attention in subjects with mild cognitive impairment: a double-blind placebo-controlled study. (PubMed.gov / NCBI) | http://www.ncbi.nlm.nih.gov/pubmed/21303262
  24. Psychoactive Substances Act 2016 (Legislation.gov.uk) | http://www.legislation.gov.uk/ukpga/2016/2/contents/enacted
Return to "Withania somnifera (botany)" page.